BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37735667)

  • 1. Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma.
    Liu R; Huang B; Shao Y; Cai Y; Liu X; Ren Z
    J Transl Med; 2023 Sep; 21(1):648. PubMed ID: 37735667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
    Luo SS; Liao XW; Zhu XD
    J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    PeerJ; 2024; 12():e16776. PubMed ID: 38274323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the Hedgehog signal pathway on the tumor immune microenvironment of gastric adenocarcinoma by integrated analysis of scRNA-seq and RNA-seq datasets.
    Zhong J; Sun Y; Wu S; Zhang T; Yang J; He Y; Liu K
    Funct Integr Genomics; 2023 Aug; 23(3):258. PubMed ID: 37526746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
    Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
    Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.
    Chen R; Sun K; Hou Y; Shen J; Chen J; Dong F; Wang X; Yang L; Zhang L
    Biomed Res Int; 2022; 2022():8776678. PubMed ID: 36467881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma.
    Wang G; Yang L; Hu M; Hu R; Wang Y; Chen B; Jiang X; Cui R
    Front Cell Dev Biol; 2021; 9():736274. PubMed ID: 34604236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
    Tu H; Zhang Q; Xue L; Bao J
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miRNA biomarkers for stomach adenocarcinoma.
    Qian H; Cui N; Zhou Q; Zhang S
    BMC Bioinformatics; 2022 May; 23(1):181. PubMed ID: 35578189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of expression profile of miRNA in stomach adenocarcinoma.
    Huo Q
    J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.